Skip to main content

Aggregator

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

11 hours 49 minutes ago
A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

TIA1 is required for microglial activation in tauopathy

12 hours 52 minutes ago
The RNA-binding protein T cell intracellular antigen-1 (TIA1) regulates cellular stress responses and tau pathology, key contributors to the pathophysiology of tauopathies, including Alzheimer's disease (AD). TIA1 acts in peripheral monocytes to inhibit inflammation, but its function in central microglia, critical to neuroinflammation and disease progression, remains unknown. Here, we crossed TIA1 microglial conditional knockout (cKO) mice (using a Cx3cr1-driven Cre element) with the PS19 P301S...
Chelsea J Webber

<em>SSH1</em> knockdown increases autophagosome formation through ATG9A recruitment and promotes tau protein degradation

12 hours 52 minutes ago
Pathological accumulation of MAPT/tau protein is a defining feature of Alzheimer disease (AD) and related tauopathies, highlighting the need to identify druggable regulators of MAPT/tau clearance. Using Drosophila behavioral assays focused on cytoskeletal remodeling pathways dysregulated in AD, we identified genes whose genetic modulation mitigates MAPT/tau-induced behavioral deficits. These modifiers were validated by histopathology and mechanistically examined in human tauopathy cell models to...
Morgan C Stephens

Education reduces dementia incidence and mitigates genetic risk

12 hours 52 minutes ago
There is little causal evidence on factors that can protect individuals against Alzheimer's Disease and Related Dementias (ADRD) risk. We study the causal effect of education on ADRD, exploiting a regression discontinuity generated by a compulsory schooling reform. ADRD was ascertained based on medical history, hospital records, and death registries, addressing concerns about selective sample attrition. We find that education reduces incidence of ADRD. Using molecular genetic data, we show that...
Silvia H Barcellos

Lessons from dog lifespan therapeutics for their human companions

12 hours 52 minutes ago
The growing evidence that existing cardio-renal-metabolic therapies, such as GLP-1 receptor agonists and SGLT2 inhibitors, confer all-cause mortality benefits has positioned them as the first wave of potential gerotherapeutics. However, repurposing these drugs for a lifespan extension indication remains constrained by trial duration, misaligned incentives, and the lack of a viable regulatory path. We highlight two parallel strategies to address these barriers: (1) identifying and validating...
Matthew Peloquin

Advanced brain age and longitudinal cognitive decline in healthy older adults

12 hours 52 minutes ago
Advanced brain age relative to chronological age may predict cognitive decline in healthy aging, but prospective evidence remains limited. We tested whether the brain age gap (BAG) predicts cognition and 5-year cognitive decline in the AGES-Reykjavik Study. Participants with structural MRI and neuropsychological data were included cross-sectionally (n = 4,606); mean age 76.4y; 58% female) and longitudinally (n = 2,561; mean follow-up 5.2y). BAG was estimated from T1-weighted MRI. Mixed-effects...
Sigfus Kristinsson

Resveratroloside alleviates senescence-associated phenotypes in vitro through the coordinated regulation of mitochondrial function and chromatin structure

12 hours 52 minutes ago
Cellular senescence is characterized by coordinated disruptions in mitochondrial function and epigenetic regulation, with perturbation of the mitochondria-chromatin axis emerging as a central hallmark of this process. Resveratrol (RSV) has been extensively investigated as a modulator of this axis; however, its clinical utility is constrained by dose-dependent cytotoxicity. Here, we evaluated the safety profile and anti-aging potential of resveratrol glucoside (R-glc), a glucosylated derivative...
Jee Hee Yoon

Lysergic acid diethylamide extends lifespan in Caenorhabditis elegans

12 hours 52 minutes ago
Aging is modulated by conserved nutrient-sensing pathways that integrate metabolic cues to regulate growth, stress resilience, and lifespan. Caloric restriction (CR) extends longevity across species, motivating the search for compounds that engage related physiology. Lysergic acid diethylamide (LSD), a classic serotonergic psychedelic with emerging therapeutic applications, remains unexplored in the context of aging. Here we show that chronic exposure to nanomolar LSD extends lifespan in...
Beatriz S Carrilho

Death receptors regulate entry to therapy-induced senescence and orchestrate addiction to IAPs

12 hours 52 minutes ago
Cytotoxic chemotherapy typically results in the elimination of a fraction of the tumor with surviving cells entering a state of persistence or premature replicative senescence that can lead to recurrence. Here, we show that therapy-induced senescence is associated with robust up-regulation of Fas and/or TRAIL-R2/DR5 death receptors in vitro and in vivo. The latter receptors restricted entry to senescence and exerted selective pressure on senescent cells through promoting assembly of proapoptotic...
Gokhan Gunay

Scientists discover a hidden messaging system deep inside the brain

14 hours 23 minutes ago
A tiny region deep within the brain has surprised scientists by revealing a remarkably sophisticated communication system. Previously thought to broadcast the same chemical signal throughout the brain, this region actually sends targeted messages that help control learning, attention, and behavior, according to new research in mice.